Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02923141 · ClinicalTrials.gov registry record · NA

Trauma Intervention for Affect Regulation, AIDS, and Substances

A NA study of Post Traumatic Stress Disorder and Human Immunodeficiency Virus, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT02923141 is a NA study of Post Traumatic Stress Disorder and Human Immunodeficiency Virus that has completed, run by University of Miami. The registered enrollment target is 16 participants, below the 1,117-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02923141, a NA study of Post Traumatic Stress Disorder and Human Immunodeficiency Virus, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The Purpose of this study is to see if it is possible to deliver an intervention that targets trauma, substance use, and engagement in HIV care with HIV-positive women.

Interventions

  • BEHAVIORAL Contingency Management
  • BEHAVIORAL Neutral Writing
  • BEHAVIORAL Expressive Writing

Study Locations (1)

Florida

  • Clinical Research Building - Miami

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2017-01
Est. Completion 2018-07
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT02923141

The ClinicalTrials.gov registry entry for NCT02923141 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,117-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (99% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 3 interventions - of which Contingency Management is the first listed.

NCT02923141 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02923141 about?

NCT02923141 is a clinical study titled "Trauma Intervention for Affect Regulation, AIDS, and Substances". The Purpose of this study is to see if it is possible to deliver an intervention that targets trauma, substance use, and engagement in HIV care with HIV-positive women.

What is the current status of trial NCT02923141?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-01. Estimated completion is 2018-07.

What conditions does trial NCT02923141 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Human Immunodeficiency Virus, Substance Related Disorder.

What interventions are being tested in trial NCT02923141?

The interventions under investigation include: Contingency Management (BEHAVIORAL), Neutral Writing (BEHAVIORAL), Expressive Writing (BEHAVIORAL).

Who is sponsoring clinical trial NCT02923141?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02923141 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.